QTREX Quantum Ltd.QTEX
Price (close)
$0.76
Market cap
$51.0M
P/E
—
Revenue (FY)
$289,000
Net income
-$13.2M
Dividend yield
—
1-year total return
-40.6%
Net margin
-4574.4%
Revenue growth
—
Debt / equity
—
What QTREX Quantum Ltd. does.
device company the research, development, manufacturing, and commercialization of proprietary life support technologies. We aim for our
in ICUs are treated with invasive mechanical ventilation. Mortality rates among patients undergoing prolonged mechanical ventilation may
exceed 50%. Mechanical ventilators are typically used when patients are unable to breathe adequately on their own due to acute respiratory
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | $0 | $0 | $289,000 |
| Net income | $16.9M | -$17.2M | -$15.0M | -$11.3M | -$11.1M | -$13.2M |
| Free cash flow | -$1.9M | -$6.9M | -$9.5M | -$9.9M | -$9.5M | -$10.0M |
More on QTEX.
- QTREX Quantum Ltd. summary
- QTREX Quantum Ltd. financial statements
- QTREX Quantum Ltd. key metrics
- QTREX Quantum Ltd. health scores and style box
- QTREX Quantum Ltd. earnings
- QTREX Quantum Ltd. dividends
- QTREX Quantum Ltd. valuation
- QTREX Quantum Ltd. ownership and insiders
- QTREX Quantum Ltd. peers
Figures from QTREX Quantum Ltd.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.